查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1525456

全球 HLA 分型市场评估：按产品与服务、按技术、按应用、按最终用户、按地区、机会、预测（2017-2031 年）

HLA Typing Market Assessment, By Products and Services, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 221 Pages | 商品交期: 3-5个工作天内

价格

全球 HLA 分型市场规模预计将从 2023 年的 13.1 亿美元增至 2031 年的 21.3 亿美元，2024-2031 年预测期间复合年增长率为 6.27%。器官移植需求的不断增长、遗传性疾病病例数量的增加、对研究活动的日益关注以及市场主要参与者推出的新产品支持了市场的增长。

Health Resource and Services Administration（HRSA）估计，美国约有 103,223 名男性、女性和儿童在全国移植等待名单上。这种增加促使器官移植病例和 HLA 分型需求的增加。由于遗传和自体免疫疾病负担的增加，研究活动不断增加，全球 HLA 分型市场规模不断扩大。American Autoimmune 估计约有 5,000 万美国人患有一种或多种自体免疫疾病。

市场领导者开发的新技术、产品和软体正在为市场创造利润丰厚的成长机会。2024 年 6 月，Thermo Fisher Scientific Inc. 宣布推出 Applied Biosystems Axiom BloodGenomiX Array和软体，用于在临床研究中进行准确的血液基因分型。这种新阵列可以在一次检测中检测血小板类型、稀有血型和组织，有助于扩展表型捐赠者血液匹配的进步。基于 DNA 的血型检测的增加预计将支持大规模基因组研究，并引入国际标准以提高输血的有效性和安全性。增加基于可扩展阵列的血型解决方案的使用预计将能够有效筛选不同的血型以进行准确匹配。

HLA 分型技术的进步支持市场扩张

领先的市场参与者和各种研究机构加强开发先进技术，预计将在未来几年为市场提供利润丰厚的成长机会。包括 PacBio 和 Illumina 在内的新一代定序 (NGS) 技术彻底改变了 HLA 分型，因为它们能够对整个 HLA 基因（包括非编码区和编码区）进行定序。

2023 年 11 月，F. Hoffmann-La Roche Ltd 推出了下一代 qPCR 系统，以应对公共卫生课题并推动个人化医疗。LightCycler PRO System预计将透过为诊断和转化研究提供灵活性和敏捷性来提供疫情回应能力。此外，2023年4月，Metropolis Healthcare Limited推出了NextGen HLA分型测试，透过分析HLA基因来识别适合器官移植、脐带血和骨髓的捐赠者。NextGen HLA 分型测试预计将帮助医生和患者确保移植后受者和供者之间 HLA 高度匹配，从而增加移植成功的可能性。

器官移植的增加推动 HLA 分型市场的成长

由于捐赠器官数量的增加而促使的器官移植数量的增加是推动全球 HLA 分型市场需求的主要因素之一。根据Organ Procurement and Transplantation Network（OPTN））的数据，2023年美国约有16,335人将在死亡时捐赠一个或多个器官，比2022年增加9.6%。器官捐赠的增加可归因于人们对该程序及其对捐赠者健康影响的认识的提高。这促进了 HLA 匹配的需求，因为它降低了与移植后併发症相关的风险，并促进健康新血球的发育和生长。捐赠者和接受者必须至少在六个 HLA 标记上配对。不匹配程度越高，患者的免疫系统就越有可能产生抗体来攻击移植物。

本报告针对全球HLA分型市场进行研究分析，提供市场规模及预测、区域市场前景、市场动态、竞争格局等。

目录

第1章 专案范围与定义

第2章 研究方法

第3章 执行摘要

第4章 全球HLA分型市场展望（2017-2031）

  • 市场规模分析与预测
    • 金额
    • 数量
  • 市占率分析及预测
    • 按产品/服务
    • 按技术
    • 按用途
    • 按最终用户
    • 按地区
    • 市场占有率分析：按公司划分（金额）（前 5 名公司及其他 - 2023 年）
  • 市场地图分析（2023）
    • 按产品/服务
    • 按技术
    • 按用途
    • 按最终用户
    • 按地区

第五章 北美HLA分型市场展望（2017-2031）

  • 市场规模分析与预测
    • 金额
    • 数量
  • 市占率分析及预测
    • 按产品/服务
    • 按技术
    • 按用途
    • 按最终用户
    • 分享：按国家/地区
  • 市场评估：依国家分类
    • 美国HLA分型市场前景，2017-2031年预测
    • 加拿大
    • 墨西哥

第六章 欧洲HLA分型市场展望（2017-2031）

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙
  • 波兰

第七章亚太HLA分型市场展望（2017-2031）

  • 印度
  • 中国
  • 日本
  • 澳大利亚
  • 越南
  • 韩国
  • 印度尼西亚
  • 菲律宾

第八章 南美HLA分型市场展望（2017-2031）

  • 巴西
  • 阿根廷

第九章 中东和非洲HLA分型市场展望（2017-2031）

  • 沙乌地阿拉伯
  • 阿拉伯联合酋长国
  • 南非
  • 以色列

第10章 供需分析

第11章 进出口分析

第12章 价值链分析

第13章波特五力分析

第14章 PESTLE分析

第15章 价格分析

第16章 市场动态

  • 市场驱动力
  • 市场课题

第 17 章市场趋势和发展

第18章 监理框架与创新

  • 临床试验
  • 监管审批

第19章 专利情况

第20章 案例研究

第21章 竞争格局

  • 前5名市场领导者的竞争矩阵
  • 前5名企业SWOT分析
  • 前10名主要企业状况
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • QIAGEN N.V.
    • F. Hoffmann-La Roche Ltd
    • bioMerieux SA
    • Illumina, Inc.
    • Becton, Dickinson and Company
    • Omixon Inc.
    • Takara Bio Inc.
    • TBG Diagnostics Limited

第22章 战略建议

第23章 关于我们公司、免责声明

Product Code: MX11677

Global HLA typing market is projected to witness a CAGR of 6.27% during the forecast period 2024-2031, growing from USD 1.31 billion in 2023 to USD 2.13 billion in 2031. The market's growth is supported by the rising requirement for organ transplantation, increasing cases of genetic diseases, growing emphasis on research activities, and novel product launches by the leading players of the market.

According to the estimates of the Health Resource and Services Administration (HRSA) approximately 103,223 men, women, and children are on the national transplant waiting list in the United States. Due to this increase, the cases of organ transplant procedures are rising, bolstering the requirement for HLA typing. The global HLA typing market size is increasing due to the rising research activities on genetic and autoimmune diseases due to their growing burden. According to the estimates of the American Autoimmune, approximately 50 million Americans are living with one or more autoimmune diseases.

The development of novel technologies, products, and software by the leading players in the market is providing lucrative growth opportunities to the market. In June 2024, Thermo Fisher Scientific Inc. introduced their Applied Biosystems Axiom BloodGenomiX Array and software for precise blood genotyping in clinical research. The new array is capable of detecting platelet types, rare blood groups, and tissues in a single assay, aiding advancements in extended phenotype donor blood matching. Increasing utilization of DNA-based blood typing is expected to support large-scale genomics research and the introduction of international standards for improving the efficacy and safety of blood transfusion. The increasing accessibility of scalable array-based blood typing solutions is expected to effectively screen various blood types for precise matching.

Technological Advancements in HLA Typing Support the Market Expansion

The increasing efforts of the key players of the market and various research institutions toward the development of advanced technologies are expected to provide lucrative growth opportunities to the market in the forecast years. Next-generation sequencing (NGS) technologies, including PacBio and Illumina, have revolutionized HLA typing as they enable the sequencing of entire HLA genes, including noncoding and coding regions.

In November 2023, F. Hoffmann-La Roche Ltd launched a next-generation qPCR system to address public health challenges and advance personalized healthcare. The LightCycler PRO System is expected to provide outbreak readiness by providing flexibility and agility for diagnostics and translational research. Additionally, in April 2023, Metropolis Healthcare Limited launched their NextGen HLA typing test for identifying suitable donors for organ transplantation, cord blood, and bone marrow by analyzing the HLA gene. The NextGen HLA typing test is expected to aid physicians, doctors, and patients in ensuring transplants at a higher HLA match percentage between the recipient and the donor, bolstering the chances of successful transplants.

Increasing Organ Transplantation Boosts HLA Typing Market Growth

The rise in organ transplant procedures due to the increasing availability of donated organs is one of the major factors bolstering the global HLA typing market demand. According to the Organ Procurement and Transplantation Network (OPTN), in 2023, approximately 16,335 individuals donated one or more organs upon their death in the United States, showcasing a 9.6% increase from 2022. The increasing donations can be attributed to the growing awareness about the procedure and the impact of the donation on donor health. This propels the requirement for HLA matching as it reduces the risks associated with post-transplant complications and promotes the development and growth of healthy new blood cells. Donors and recipients should have a match of at least 6 HLA markers, as a high degree of mismatch augments the chances of antibody production from the immune system of the patient, which can attack the graft.

Diagnostics Segment Expected to Witness Significant Growth

The growth of the segment is supported by the rising requirement for organ transplantation and increasing cases of autoimmune and genetic diseases. For instance, the HLA-B27 test is conducted to confirm or dismiss suspected cases of ankylosing spondylitis (AS), juvenile rheumatoid arthritis, and reactive arthritis. The test aids healthcare professionals in determining the presence or absence of the HLA-B27 protein on the surface of the white blood cells in individuals. Additionally, the expansion of the segment is supported by the rising collaborations between different diagnostic and biotech companies to support the development of HLA typing kits. In November 2023, OSE Immunotherapeutics and GenDx announced the partnership for developing NGSengine software and NGSgo HLA-A typing kit as a companion diagnostic (CDx) for cancer vaccines. With the partnership, the companies aim to validate and develop a CDx test for epitope-based cancer vaccines to improve the survival and the quality of patients' lives.

North America Holds Significant Market Share

The presence of leading market players, rising requirements for organ transplantation in the region, novel product launches, and presence of well-established healthcare infrastructure are some of the major factors boosting the market's growth. According to estimates from the United Network for Organ Sharing (UNOS), in 2023 over 46,000 organ transplants were performed in the United States. This increase propels the market demand as HLA typing is one of the essential components for matching hematopoietic cells between the recipients and the donors for improving patient outcomes by aiding patients in avoiding graft-versus-host disease (GVHD) and acute graft rejection.

The strong presence of various research institutions and increasing investments in research activities are another significant factors supporting the market's expansion. For instance, the Memorial Sloan Kettering Cancer Center is conducting an interventional study to evaluate if the addition of specific genetic factors to the process of selecting a stem cell donor reduces the chances of leukemia coming back in patients after the bone marrow has been transplanted. The study is expected to conclude in May 2025 and aims to demonstrate that patients with adult acute myeloid leukemia (AML) who have donors with specific HLA and killer immunoglobulin-like receptors (KIR) genes have better outcomes.

Future Market Scenario (2024 - 2031F)

Market demand is expected to increase significantly over the forecast period due to the rise in the number of organ transplantations. Advancements in bioinformatics and nanopore technology are expected to enhance the efficiency, speed, and reliability of HLA genotyping, revolutionizing their clinical applications and immunogenetics.

The increasing autoimmune diseases incidences are bolstering the requirement for HLA typing, as it can provide insights about various risks of autoimmune diseases and guide the development of prophylactic interventions for reducing the risks in individuals that are susceptible to the disease.

The growing efforts of the key market players towards the development of novel technologies and products is another major factor expected to boost the growth of the market in the coming years.

Key Players Landscape and Outlook

The rising efforts of the key players of the market towards the development of novel products and technologies and increasing receival of approvals from various regulatory bodies are supporting the global HLA typing market growth. These efforts and approvals aid healthcare professionals in accurately diagnosing various diseases and disorders and support the introduction of new products to meet the evolving requirements of the healthcare industry.

In December 2022, Thermo Fisher Scientific Inc. announced that they received De Novo Classification from the US Food and Drug Administration (FDA) for their SeCore CDx HLA Sequencing System, the system allows clinicians to identify patients that will benefit from this immunotherapy breakthrough. The company plans on partnering with leading companies for commercializing and developing immunotherapies for meeting the unmet requirements of patients for a wide range of diseases.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global HLA Typing Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Products and Services
      • 4.2.1.1. Instruments
      • 4.2.1.2. Reagents and Consumables
      • 4.2.1.3. Software and Services
    • 4.2.2. By Technology
      • 4.2.2.1. Molecular Assays
        • 4.2.2.1.1. Sequencing-based Molecular Assays
          • 4.2.2.1.1.1. Sanger Sequencing
          • 4.2.2.1.1.2. Next-generation Sequencing
          • 4.2.2.1.1.3. Pyrosequencing
        • 4.2.2.1.2. PCR-based Molecular Assays
          • 4.2.2.1.2.1. Sequence-specific Primer-PCR
          • 4.2.2.1.2.2. Sequence-specific Oligonucleotide-PCR
          • 4.2.2.1.2.3. Others
      • 4.2.2.2. Non-molecular Assays
    • 4.2.3. By Application
      • 4.2.3.1. Diagnostics
        • 4.2.3.1.1. Infectious Diseases Diagnostics
        • 4.2.3.1.2. Cancer Diagnosis and Prevention
        • 4.2.3.1.3. Transmission Therapy
        • 4.2.3.1.4. Donor Recipient Cross-Matching
      • 4.2.3.2. Research
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals and Transplant Centers
      • 4.2.4.2. Commercial Service Providers
      • 4.2.4.3. Research Labs and Academic Institutes
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Products and Services
    • 4.3.2. By Technology
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America HLA Typing Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Products and Services
      • 5.2.1.1. Instruments
      • 5.2.1.2. Reagents and Consumables
      • 5.2.1.3. Software and Services
    • 5.2.2. By Technology
      • 5.2.2.1. Molecular Assays
        • 5.2.2.1.1. Sequencing-based Molecular Assays
          • 5.2.2.1.1.1. Sanger Sequencing
          • 5.2.2.1.1.2. Next-generation Sequencing
          • 5.2.2.1.1.3. Pyrosequencing
        • 5.2.2.1.2. PCR-based Molecular Assays
          • 5.2.2.1.2.1. Sequence-specific Primer-PCR
          • 5.2.2.1.2.2. Sequence-specific Oligonucleotide-PCR
          • 5.2.2.1.2.3. Others
      • 5.2.2.2. Non-molecular Assays
    • 5.2.3. By Application
      • 5.2.3.1. Diagnostics
        • 5.2.3.1.1. Infectious Diseases Diagnostics
        • 5.2.3.1.2. Cancer Diagnosis and Prevention
        • 5.2.3.1.3. Transmission Therapy
        • 5.2.3.1.4. Donor Recipient Cross-Matching
      • 5.2.3.2. Research
    • 5.2.4. By End-user
      • 5.2.4.1. Hospitals and Transplant Centers
      • 5.2.4.2. Commercial Service Providers
      • 5.2.4.3. Research Labs and Academic Institutes
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States HLA Typing Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Products and Services
          • 5.3.1.2.1.1. Instruments
          • 5.3.1.2.1.2. Reagents and Consumables
          • 5.3.1.2.1.3. Software and Services
        • 5.3.1.2.2. By Technology
          • 5.3.1.2.2.1. Molecular Assays
          • 5.3.1.2.2.1.1. Sequencing-based Molecular Assays
          • 5.3.1.2.2.1.1.1. Sanger Sequencing
          • 5.3.1.2.2.1.1.2. Next-generation Sequencing
          • 5.3.1.2.2.1.1.3. Pyrosequencing
          • 5.3.1.2.2.1.2. PCR-based Molecular Assays
          • 5.3.1.2.2.1.2.1. Sequence-specific Primer-PCR
          • 5.3.1.2.2.1.2.2. Sequence-specific Oligonucleotide-PCR
          • 5.3.1.2.2.1.2.3. Others
          • 5.3.1.2.2.2. Non-molecular Assays
        • 5.3.1.2.3. By Application
          • 5.3.1.2.3.1. Diagnostics
          • 5.3.1.2.3.1.1. Infectious Diseases Diagnostics
          • 5.3.1.2.3.1.2. Cancer Diagnosis and Prevention
          • 5.3.1.2.3.1.3. Transmission Therapy
          • 5.3.1.2.3.1.4. Donor Recipient Cross-Matching
          • 5.3.1.2.3.2. Research
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Hospitals and Transplant Centers
          • 5.3.1.2.4.2. Commercial Service Providers
          • 5.3.1.2.4.3. Research Labs and Academic Institutes
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe HLA Typing Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific HLA Typing Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America HLA Typing Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa HLA Typing Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Thermo Fisher Scientific Inc.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. Bio-Rad Laboratories, Inc.
    • 21.3.3. QIAGEN N.V.
    • 21.3.4. F. Hoffmann-La Roche Ltd
    • 21.3.5. bioMerieux SA
    • 21.3.6. Illumina, Inc.
    • 21.3.7. Becton, Dickinson and Company
    • 21.3.8. Omixon Inc.
    • 21.3.9. Takara Bio Inc.
    • 21.3.10. TBG Diagnostics Limited

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 4. Global HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 6. Global HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global HLA Typing Market Share (%), By Region, 2017-2031F
  • Figure 8. North America HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 11. North America HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 12. North America HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 13. North America HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America HLA Typing Market Share (%), By Country, 2017-2031F
  • Figure 15. United States HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 18. United States HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 19. United States HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 20. United States HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 24. Canada HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 25. Canada HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 30. Mexico HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 31. Mexico HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 36. Europe HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 37. Europe HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe HLA Typing Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 43. Germany HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 44. Germany HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 46. France HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 49. France HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 50. France HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 51. France HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 55. Italy HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 56. Italy HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 61. United Kingdom HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 62. United Kingdom HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 67. Russia HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 68. Russia HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 73. Netherlands HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 74. Netherlands HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 79. Spain HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 80. Spain HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 85. Turkey HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 86. Turkey HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 91. Poland HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 92. Poland HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 97. South America HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 98. South America HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 99. South America HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America HLA Typing Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 104. Brazil HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 105. Brazil HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 110. Argentina HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 111. Argentina HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 116. Asia-Pacific HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 117. Asia-Pacific HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific HLA Typing Market Share (%), By Country, 2017-2031F
  • Figure 120. India HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 123. India HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 124. India HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 125. India HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 126. China HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 129. China HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 130. China HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 131. China HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 135. Japan HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 136. Japan HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 141. Australia HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 142. Australia HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 147. Vietnam HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 148. Vietnam HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 153. South Korea HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 154. South Korea HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 159. Indonesia HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 160. Indonesia HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 165. Philippines HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 166. Philippines HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 171. Middle East & Africa HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 172. Middle East & Africa HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa HLA Typing Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 178. Saudi Arabia HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 179. Saudi Arabia HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 184. UAE HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 185. UAE HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 190. South Africa HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 191. South Africa HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Products and Services Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023